KVUE
Kenvue Inc.Consumer Defensive · $34.2B market cap
Verdict
Share price
$17.20
close of Oct 3, 2026
Fair value
$20.08
Sticker Price
Payback Price
$8.03
buy price
KVUE is Undervalued: at $17.20 it trades 14% below its fair value of $20.08. Its buy price (Payback Price) is $8.03, 53% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.
How we valued it
Free Cash Flow. Sales grew 0% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.
Business quality
2 of 5 clear the 10% bar. What are the Big Five?
Follow KVUE
Get notified when it reaches its buy price of $8.03. Free.
Create a free accountSuperinvestors
4 of the investors we track hold KVUE. In Q2 2026, 2 added. Who we track
Yacktman Asset Management
Yacktman Asset Management · as of Q2 2026
$153.9M
8,051,004 shares
David Einhorn
Greenlight Capital · as of Q4 2023
$11.9M
554,490 shares
Lee Ainslie
Maverick Capital · as of Q2 2026
$3.3M
173,991 shares
Tweedy Browne
Tweedy Browne · as of Q2 2026
$1.4M
72,949 shares
Moves in Q2 2026
Added: Tweedy Browne, Lee Ainslie
Insider activity
Since Jun 29, 2026: no open-market purchases and 3 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent…
Household & Personal Products
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works